Collegium Pharma Shareholders Poised for a Pain-Free 2025

Collegium Pharmaceutical stands poised for a promising 2025, with innovative pain management solutions on the horizon. As their pipeline expands, shareholders could see significant returns, potentially making the year a pain-free experience in more ways than one.